B. Agerberth et al., PR-39, A PROLINE-RICH PEPTIDE ANTIBIOTIC FROM PIG, AND FALL-39, A TENTATIVE HUMAN COUNTERPART, Veterinary immunology and immunopathology, 54(1-4), 1996, pp. 127-131
The peptide antibiotic PR-39 was originally isolated from the upper pa
rt of pig intestine. It has antibacterial activity against Gram negati
ve bacteria at concentrations comparable with tetracycline. Studies of
the mechanism of action showed that PR-39 inhibits both DNA and prote
in synthesis. Recently, PR-39 was found in wound fluid and was shown t
o have inductive activity on matrix components as part of the wound re
pair process, We have now sequenced the complete gene and possible med
iators of its expression will be discussed, Our attempts to characteri
ze the human counterpart of PR-39 by probing for the well conserved pr
epro-part led to a different peptide antibiotic. A clone containing th
e coding information for this new peptide was isolated from a human bo
ne marrow cDNA library. The putative human peptide antibiotic was desi
gnated FALL-39 after the first four residues and the total number of r
esidues. All human peptide antibiotics previously isolated (or predict
ed) belong to the defensin family with three disulfide bridges, while
FALL-39 lacks cysteine, The clone for the prepro-FALL-39 encodes a cat
helin-like precursor protein with 170 amino acid residues, We have pos
tulated a dibasic processing site for the mature FALL-39 and chemicall
y synthesized the peptide. In the presence of the basal medium E, synt
hetic FALL-39 was highly active against Escherichia coli D21 and Bacil
lus megaterium Bm11. Residues 13-34 in FALL-39 can be predicted to for
m a perfect amphipatic helix and CD spectra showed that medium E induc
ed 30% helix formation in FALL-39. By Northern blot analyses the trans
cript was located in bone marrow and testis, The structure of the gene
and the chromosomal location is under investigation.